Company Search:
Advanced Search
Sponsored Links
Dae Han New Pharm Co., Ltd. Company Snapshot
Dae Han New Pharm Co., Ltd. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dae Han New Pharm Co., Ltd. with three other companies in this sector in South Korea: Celltrion Pharm Incorporated (2017 sales of 135.86 billion Korean Won [US$120.64 million] of which 100% was Pharmaceutical), Reyon Pharmaceutical Co Ltd (126.25 billion Korean Won [US$112.11 million] ), and Hyundai Pharmaceutical Company Limited (130.48 billion Korean Won [US$115.87 million] of which 88% was Pharmaceutical).

Sales Analysis. Dae Han New Pharm Co., Ltd. reported sales of 130.82 billion Korean Won (US$116.16 million) for the year ending December of 2017. This represents an increase of 19.6% versus 2016, when the company's sales were 109.40 billion Korean Won. Sales at Dae Han New Pharm Co., Ltd. have increased during each of the previous five years (and since 2012, sales have increased a total of 172%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dae Han New Pharm Co., Ltd.
  Stock Performance Chart for Dae Han New Pharm Co., Ltd.
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 10,900
(Figures in Korean Won)
1 Week 0.0%   13 Weeks -1.4%  
4 Weeks 7.9%   52 Weeks -23.0%  
Dae Han New Pharm Co., Ltd. Key Data:
  Ticker: 054670 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 130,816,028,979
(Year Ending Jan 2018).
Employees: 324
  Currency: Korean Won Market Cap: 152,984,650,100
  Fiscal Yr Ends: December Shares Outstanding: 14,035,289
  Share Type: Common Closely Held Shares: 5,755,792
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.